Current Environment:

Jennifer Krajewski | Medical Services

Jennifer Krajewski | Education

Medical School

Finch University of Health Sciences/The Chicago Medical

2003, Chicago, IL


Children’s National Medical Center

2006, Washington, DC


Columbia University Medical Center

2009, New York, NY

Jennifer Krajewski | Professional History

Jennifer Krajewski, MD, received her medical degree from Finch University of Health Sciences/The Chicago Medical School in 2003. She then completed her general pediatric residency at Children’s National Medical Center in Washington, DC in 2006. During this time, she developed a palliative care education curriculum for the residents, for which she won a prize for the best educational research project amongst the residents. She completed her fellowship in pediatric hematology/oncology at Columbia University Medical Center in New York City in 2009. She served as the co-chief fellow during her last year, and was awarded the best translational research prize amongst all graduating pediatric fellows at Columbia for her basic science research on NOTCH signaling in neuroblastoma. She was also a co-investigator in a quality improvement project examining the role of a treatment pathway for pediatric sickle cell patients presenting to the emergency department with vaso-occlusive crisis, and the results were published in 2013 in the journal Pediatric Blood and Cancer. She is board certified in both general pediatrics and pediatric hematology/oncology. She joined the Pediatric Blood and Bone Marrow Transplantation Service at HackensackUMC in 2010, where she was primarily responsible for all BMT patients with hemoglobinopathies & lymphomas, as well as all patients needing autologous BMTs. Her primary interest is in curative therapies for sickle cell anemia. Her research at Hackensack included two investigator-initiated protocols for reduced intensity stem cell transplant in sickle cell patients ages 2-30, and she was the institutional Principal Investigator for multiple national trials on the use of BMT as a cure for sickle cell disease. She is also a member of the Sickle Cell Transplant Advocacy and Research Alliance (STAR), which is an international organization created to specifically investigate the best way to use stem cell transplant to cure sickle cell disease. She served as the co-chair of the STAR Advocacy/Education/Outreach committee from 2018 until 2022. She co-authored a review article on the use of stem cell transplantation as a cure for sickle cell anemia published in the journal Bone Marrow Transplantation in 2012, has had multiple abstracts accepted to national meetings on the preliminary results from her institutional trials, and has been a co-author on multiple abstracts and articles stemming from her participation in multicenter trials, including those from STAR. Dr. Krajewski is excited to join the pediatric BMT team at Westchester Medical Center where she can continue to help cure patients in need of BMT as well as continue to do research on how best to offer curative therapy to all patients with sickle cell disease.